Lifecore Biomedical, Inc.Lifecore Biomedical, Inc.Lifecore Biomedical, Inc.

Lifecore Biomedical, Inc.

No trades
See on Supercharts
Market capitalization
‪188.47 M‬USD
‪−99.56 M‬USD
‪103.27 M‬USD
‪30.00 M‬
Beta (1Y)
−0.02

About Lifecore Biomedical, Inc.

CEO
James G. Hall
Headquarters
Chaska
Employees (FY)
459
Founded
1986
ISIN
US5147661046
FIGI
BBG000G1FS10
Lifecore Biomedical, Inc. is a contract development and manufacturing organization, which engages in the provision of differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It operates through the following business segments: Lifecore, Curation Foods, and Others. The Lifecore segment focuses on selling products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the Ophthalmic, Orthopedic and other markets. The Curation Foods segment is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels. The Others segment is Corporate, which includes corporate general and administrative expenses, Non Lifecore and non-Curation Food interest income, interest expense, and income tax expenses. The company was founded by Ray Stewart on October 31, 1986 and is headquartered in Chaska, MN.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of LFCR is 6.06 USD — it has decreased by 1.78% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Lifecore Biomedical, Inc. stocks are traded under the ticker LFCR.
Lifecore Biomedical, Inc. is going to release the next earnings report on Apr 12, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Lifecore Biomedical, Inc. has a max estimate of 6.00 USD and a min estimate of 6.00 USD.
LFCR earnings for the last quarter are −0.33 USD whereas the estimation was −0.23 USD which accounts for −43.48% surprise. Estimated earnings for the next quarter are −0.13 USD. See more details about Lifecore Biomedical, Inc. earnings.
Lifecore Biomedical, Inc. revenue for the last quarter amounts to ‪24.80 M‬ USD despite the estimated figure of ‪24.55 M‬ USD. In the next quarter revenue is expected to reach ‪29.85 M‬ USD.
Yes, you can track Lifecore Biomedical, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, LFCR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Lifecore Biomedical, Inc. stock right from TradingView charts — choose your broker and connect to your account.
LFCR reached its all-time high on Jul 2, 1996 with the price of 20.75 USD, and its all-time low was 1.51 USD and was reached on Sep 13, 2002.
See other stocks reaching their highest and lowest prices.
As of Apr 13, 2024, the company has 459.00 employees. See our rating of the largest employees — is Lifecore Biomedical, Inc. on this list?